Agastiya Biotech - Crunchbase Company Profile & Funding

Overview

Agastiya Biotech

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Agastiya Biotech

CB Rank

610685

Agastiya Biotech is a new drug development company delivering innovative pharmaceutical products to the marketplace.

Founded

obfuscation

Private

Temecula, California, United States

1-10

www.agastiyabiotech.com/

Biotechnology

Health Care

Health Diagnostics

Pharmaceutical

Key People

Dr. Baskaran Pillai: Chairman and Founder
Dr. Dinesh MG: Chief Scientific Officer

Details

Legal Name

Agastiya Biotech LLC

Operating Status

Active

Company Type

For Profit

Founders

Dr. Baskaran Pillai

About the Company

Agastiya Biotech is a new drug development company delivering innovative pharmaceutical products to the marketplace. The company’s innovative methodologies have created several novel small molecules with patents for different types of cancer including the most challenging leukemia and pancreatic cancer. They developing novel molecular formulations

for breakthrough therapies in cancer stem cells, tumor suppressor genes, and oncogene mutations.

Agastiya Biotech pipeline is focused on areas for which the unmet medical need is greatest and for which there are few effective therapies. The company has discovered its previously tested anti-cancer small molecule AB001 to be working as well for SARS-CoV-2 virus therapeutics in silico studies.

Agastiya Biotech was founded in 2019 and is based in Temecula, California, USA.

Phone Number

+1-951-234-3142

Contact Email

media@agastiyabiotech.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

AB001

An orally available small molecule therapeutic targeting multiple cancer mechanisms including pan-KRAS mutations, PD-L1 immunomodulation, and cancer stem cell eradication.